Journal articles on the topic 'ACE-011'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'ACE-011.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Abdulkadyrov, Kudrat M., Galina N. Salogub, Nuriet K. Khuazheva, Rachel Woolf, Eric Haltom, Niels G. Borgstein, Robert Knight, Gary Renshaw, Yijun Yang, and Matthew L. Sherman. "ACE-011, a Soluble Activin Receptor Type Iia IgG-Fc Fusion Protein, Increases Hemoglobin (Hb) and Improves Bone Lesions in Multiple Myeloma Patients Receiving Myelosuppressive Chemotherapy: Preliminary Analysis." Blood 114, no. 22 (November 20, 2009): 749. http://dx.doi.org/10.1182/blood.v114.22.749.749.
Full textKim, Kenneth T., Niels G. Borgstein, Yijun Yang, Eric Haltom, Louisa Mook, Michelle D. Ababa, Sandeep K. Reddy, and Matthew Leigh Sherman. "ACE-011, a Soluble Activin Receptor Type IIa IgG-Fc Fusion Protein, Increases Hemoglobin and Hematocrit Levels in Postmenopausal Healthy Women." Blood 112, no. 11 (November 16, 2008): 3866. http://dx.doi.org/10.1182/blood.v112.11.3866.3866.
Full textBose, Prithviraj, Naveen Pemmaraju, Lucia Masarova, Sharon D. Bledsoe, Naval Daver, Elias Jabbour, Tapan M. Kadia, et al. "Sotatercept (ACE-011) for Anemia of Myelofibrosis: A Phase 2 Study." Blood 136, Supplement 1 (November 5, 2020): 10–11. http://dx.doi.org/10.1182/blood-2020-140441.
Full textBose, P., N. Pemmaraju, N. Daver, E. Jabbour, S. Bledsoe, T. Kadia, Z. Estrov, et al. "S829 SOTATERCEPT (ACE-011) IN SUBJECTS WITH MPN-ASSOCIATED MYELOFIBROSIS AND ANEMIA." HemaSphere 3, S1 (June 2019): 367–68. http://dx.doi.org/10.1097/01.hs9.0000561596.81498.79.
Full textGarbowski, Maciej W., Olivier Hermine, Maria Domenica Cappellini, Raffaella Origa, Gian Luca Forni, Ersi Voskaridou, Frédéric Galactéros, et al. "GDF15 and Erythroferrone Mark Erythropoietic Response to ACE-011 (Sotatercept) in Thalassemia." Blood 132, Supplement 1 (November 29, 2018): 3633. http://dx.doi.org/10.1182/blood-2018-99-111770.
Full textBose, Prithviraj, Naval Daver, Elias J. Jabbour, Allison Pike, Kate J. Newberry, Lingsha Zhou, Sherry Pierce, Xuemei Wang, Hagop M. Kantarjian, and Srdan Verstovsek. "Phase-2 Study of Sotatercept (ACE-011) in Myeloproliferative Neoplasm-Associated Myelofibrosis and Anemia." Blood 128, no. 22 (December 2, 2016): 478. http://dx.doi.org/10.1182/blood.v128.22.478.478.
Full textReichel, Christian, Letizia Farmer, Günter Gmeiner, Katja Walpurgis, and Mario Thevis. "Detection of Sotatercept (ACE-011) in human serum by SAR-PAGE and western single blotting." Drug Testing and Analysis 10, no. 6 (December 27, 2017): 927–37. http://dx.doi.org/10.1002/dta.2346.
Full textEar, Jason, Haigen Huang, Zahra Tehrani, Victoria Sung, Thomas Daniel, Rajesh Chopra, and Shuo Lin. "RAP-011 Efficiently Rescues Erythropoiesis In Zebrafish Models Of Diamond Blackfan Anemia." Blood 122, no. 21 (November 15, 2013): 3702. http://dx.doi.org/10.1182/blood.v122.21.3702.3702.
Full textVallet, Sonia, Kishan Patel, Diana Cirstea, Katie Luly, Samantha Pozzi, Loredana Santo, Homare Eda, et al. "Lenalidomide In Combination with the Activin Receptor Type II Murine Fc Protein RAP-011: Preclinical Rationale for a Novel Anti-Myeloma Strategy." Blood 116, no. 21 (November 19, 2010): 4075. http://dx.doi.org/10.1182/blood.v116.21.4075.4075.
Full textRuckle, Jon, Mark Jacobs, William Kramer, Amelia E. Pearsall, Ravindra Kumar, Kathryn W. Underwood, Jasbir Seehra, Yijun Yang, Carolyn H. Condon, and Matthew L. Sherman. "Single-Dose, Randomized, Double-Blind, Placebo-Controlled Study of ACE-011 (ActRIIA-IgG1) in Postmenopausal Women*." Journal of Bone and Mineral Research 24, no. 4 (April 2009): 744–52. http://dx.doi.org/10.1359/jbmr.081208.
Full textDe Rosa, Gianluca, Immacolata Andolfo, Roberta Marra, Francesco Manna, Barbara Eleni Rosato, Achille Iolascon, and Roberta Russo. "RAP-011 Rescues the Disease Phenotype in a Cellular Model of Congenital Dyserythropoietic Anemia Type II by Inhibiting the SMAD2-3 Pathway." International Journal of Molecular Sciences 21, no. 15 (August 4, 2020): 5577. http://dx.doi.org/10.3390/ijms21155577.
Full textBose, Prithviraj, Lucia Masarova, Naveen Pemmaraju, Sharon D. Bledsoe, Naval Daver, Elias J. Jabbour, Tapan M. Kadia, et al. "Final Results of a Phase 2 Study of Sotatercept (ACE-011) for Anemia of MPN-Associated Myelofibrosis." Blood 138, Supplement 1 (November 5, 2021): 144. http://dx.doi.org/10.1182/blood-2021-150908.
Full textBorgstein, Niels. "ACE-011, a Soluble Activin Receptor Type IIA IgG-Fc Fusion Protein, Increases BMD in Postmenopausal Healthy Women." Journal of Clinical Densitometry 12, no. 3 (July 2009): 388. http://dx.doi.org/10.1016/j.jocd.2009.03.051.
Full textChen, Nianhang, Adberrahmane Laadem, Matthew L. Sherman, Simon Zhou, Victoria Sung, Maria Palmisano, and Rajesh Chopra. "Exposures and Erythropoietic Responses to Sotatercept (ACE-011) in Healthy Volunteers and Cancer Patients: Implications for Mechanism of Action." Blood 120, no. 21 (November 16, 2012): 3454. http://dx.doi.org/10.1182/blood.v120.21.3454.3454.
Full textCarrancio, Soraya, Jennifer A. Markovics, Piu Wong, Jim Leisten, Matthew C. Groza, Heather K. Raymon, Carla Heise, Rajesh Chopra, Tom O. Daniel, and Victoria Sung. "Sotatercept, an Activin Receptor IIa Ligand Trap, Acts Through Bone Marrow Accessory Cells to Promote Late-Stage Erythropoiesis and a Rapid Induction of Red Blood Cell Number and Hemoglobin." Blood 120, no. 21 (November 16, 2012): 372. http://dx.doi.org/10.1182/blood.v120.21.372.372.
Full textIancu-Rubin, Camelia, Goar Mosoyan, Jiapeng Wang, Thomas Kraus, Victoria Sung, and Ronald Hoffman. "Stromal cell-mediated inhibition of erythropoiesis can be attenuated by Sotatercept (ACE-011), an activin receptor type II ligand trap." Experimental Hematology 41, no. 2 (February 2013): 155–66. http://dx.doi.org/10.1016/j.exphem.2012.12.002.
Full textMulivor, Aaron W., Denise Barbosa, Ravi Kumar, Matthew Leigh Sherman, Jas Seehra, and R. Scott Pearsall. "RAP-011, a Soluble Activin Receptor Type IIa Murine IgG-Fc Fusion Protein, Prevents Chemotherapy Induced Anemia." Blood 114, no. 22 (November 20, 2009): 161. http://dx.doi.org/10.1182/blood.v114.22.161.161.
Full textIancu-Rubin, Camelia, Goar Mosoyan, Jiapeng Wang, Thomas Kraus, and Ronald Hoffman. "Stromal Cells-Mediated Inhibition of Erythropoiesis Can Be Counteracted by Sotatercept (ACE-011), an Activin Receptor Type II (ActRIIA) Fusion Protein." Blood 120, no. 21 (November 16, 2012): 1254. http://dx.doi.org/10.1182/blood.v120.21.1254.1254.
Full textWalpurgis, Katja, Andreas Thomas, Matthias Vogel, Christian Reichel, Hans Geyer, Wilhelm Schänzer, and Mario Thevis. "Testing for the erythropoiesis-stimulating agent Sotatercept/ACE-011 (ActRIIA-Fc) in serum by means of Western blotting and LC-HRMS." Drug Testing and Analysis 8, no. 11-12 (October 13, 2016): 1152–61. http://dx.doi.org/10.1002/dta.2093.
Full textLotinun, Sutada, R. Scott Pearsall, Monique V. Davies, Tod H. Marvell, Travis E. Monnell, Jeffrey Ucran, Roberto J. Fajardo, et al. "A soluble activin receptor Type IIA fusion protein (ACE-011) increases bone mass via a dual anabolic-antiresorptive effect in Cynomolgus monkeys." Bone 46, no. 4 (April 2010): 1082–88. http://dx.doi.org/10.1016/j.bone.2010.01.370.
Full textVallet, Sonia, Siddhartha Mukherjee, Nileshwari Vaghela, Samantha Pozzi, Loredana Santo, Diana Cirstea, Mariateresa Fulciniti, et al. "Restoration of Bone Balance Via Activin a Inhibition Results in Anti-Myeloma Activity." Blood 112, no. 11 (November 16, 2008): 645. http://dx.doi.org/10.1182/blood.v112.11.645.645.
Full textYee, Andrew J., Jacob P. Laubach, Ajay K. Nooka, Elizabeth K. O'Donnell, Edie A. Weller, Nicole R. Couture, Ellen E. Wallace, et al. "Phase 1 Dose-Escalation Study of Sotatercept (ACE-011) in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma." Blood 126, no. 23 (December 3, 2015): 4241. http://dx.doi.org/10.1182/blood.v126.23.4241.4241.
Full textSmith, William T., John Havill, Nelson Kopyt, Jeffrey Kaupke, Daniel Aversa, and Nianhang Chen. "FP661LONG-TERM EFFECTS OF 3 DOSE LEVELS OF SOTATERCEPT COMPARED WITH PLACEBO FOR CORRECTION OF ANEMIA IN HEMODIALYSIS SUBJECTS: INTERIM ANALYSIS OF ACE-011-REN-001." Nephrology Dialysis Transplantation 30, suppl_3 (May 2015): iii295. http://dx.doi.org/10.1093/ndt/gfv182.09.
Full textCappellini, Maria-Domenica, John Porter, Raffaella Origa, Gian Luca Forni, Adberrahmane Laadem, Frédéric Galacteros, Dimana Miteva, et al. "A Phase 2a, Open-Label, Dose-Finding Study To Determine The Safety and Tolerability Of Sotatercept (ACE-011) In Adults With Beta (β)-Thalassemia: Interim Results." Blood 122, no. 21 (November 15, 2013): 3448. http://dx.doi.org/10.1182/blood.v122.21.3448.3448.
Full textSmith, William, Hartmut Malluche, and Keith Hruska. "SP645QUANTITATIVE COMPUTED TOMOGRAPHY RESULTS FOR BONE MASS AND ABDOMINAL AORTIC VASCULAR CALCIFICATION IN HEMODIALYSIS SUBJECTS TREATED WITH ESCALATING DOSE LEVELS OF SOTATERCEPT: INTERIM ANALYSIS OF ACE-011-REN-001." Nephrology Dialysis Transplantation 30, suppl_3 (May 2015): iii591. http://dx.doi.org/10.1093/ndt/gfv199.11.
Full textKlotz, B., L. Seefried, R. Ebert, and F. Jakob. "Activin-Antagonisten in der Therapie der Osteoporose." Osteologie 20, no. 03 (2011): 217–21. http://dx.doi.org/10.1055/s-0037-1619996.
Full textKomrokji, R., G. Garcia-Manero, L. Ades, A. Laadem, B. Vo, T. Prebet, A. Stamatoullas, et al. "14 A PHASE 2, DOSE-FINDING STUDY OF SOTATERCEPT (ACE-011) IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (MDS) OR NON-PROLIFERATIVE CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) AND ANEMIA REQUIRING TRANSFUSION." Leukemia Research 39 (April 2015): S5—S6. http://dx.doi.org/10.1016/s0145-2126(15)30015-1.
Full textVecchio, Lucia Del, and Francesco Locatelli. "New Treatment Approaches in Chronic Kidney Disease-associated Anaemia." European Oncology & Haematology 07, no. 02 (2011): 132. http://dx.doi.org/10.17925/eoh.2011.07.02.132.
Full textRaftopoulos, H., A. Laadem, M. Puccio, and R. D. Knight. "A phase II/III study of sotatercept (ACE-011), an activin antagonist, for chemotherapy-induced anemia in patients with metastatic non-small cell lung cancer treated with first-line platinum-based chemotherapy." Journal of Clinical Oncology 29, no. 15_suppl (May 20, 2011): TPS235. http://dx.doi.org/10.1200/jco.2011.29.15_suppl.tps235.
Full textRaftopoulos, Haralambos, Abderrahmane Laadem, Paul J. Hesketh, Jerome Goldschmidt, Nashat Gabrail, Cynthia Osborne, Muhammad Ali, et al. "Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based chemotherapeutic regimens: results from two phase 2 studies." Supportive Care in Cancer 24, no. 4 (September 14, 2015): 1517–25. http://dx.doi.org/10.1007/s00520-015-2929-9.
Full textKomrokji, Rami S., Guillermo Garcia-Manero, Lionel Ades, Abderrahmane Laadem, Bond Vo, Thomas Prebet, Aspasia Stamatoullas, et al. "An Open-Label, Phase 2, Dose-Finding Study of Sotatercept (ACE-011) in Patients with Low or Intermediate-1 (Int-1)-Risk Myelodysplastic Syndromes (MDS) or Non-Proliferative Chronic Myelomonocytic Leukemia (CMML) and Anemia Requiring Transfusion." Blood 124, no. 21 (December 6, 2014): 3251. http://dx.doi.org/10.1182/blood.v124.21.3251.3251.
Full textVasekar, Monali, and Timothy J. Craig. "ACE Inhibitor–Induced Angioedema." Current Allergy and Asthma Reports 12, no. 1 (November 30, 2011): 72–78. http://dx.doi.org/10.1007/s11882-011-0238-z.
Full textMaurin, Corantin, Zhiguo He, Marielle Mentek, Paul Verhoeven, Sylvie Pillet, Thomas Bourlet, Françoise Rogues, et al. "Exploration of the ocular surface infection by SARS-CoV-2 and implications for corneal donation: An ex vivo study." PLOS Medicine 19, no. 3 (March 1, 2022): e1003922. http://dx.doi.org/10.1371/journal.pmed.1003922.
Full textNawaz, Syed Kashif, and Shahida Hasnain. "Association of ACE ID and ACE G2350A polymorphism with increased blood pressure in persons exposed to different sound levels in Pakistan." International Archives of Occupational and Environmental Health 84, no. 4 (February 9, 2011): 355–60. http://dx.doi.org/10.1007/s00420-011-0619-6.
Full textNguyen, V. M., T. T. Tran, and H. N. Vo. "The study of angiotensin converting enzyme isolation from crossbred rabbit lung and enzyme storage capacity in frozen conditions." Food Research 4, no. 4 (March 26, 2020): 1082–88. http://dx.doi.org/10.26656/fr.2017.4(4).011.
Full textKim, Young Ree, Hyun Ju Kim, Mi Hee Kong, Keun Hwa Lee, Sun Hyung Kim, Sung Ha Kang, and Seung Ho Hong. "The ACE polymorphism is associated with BMI in patients with metabolic syndrome." Genes & Genomics 33, no. 4 (August 2011): 343–48. http://dx.doi.org/10.1007/s13258-011-0054-9.
Full textGaratachea, Nuria, Carmen Fiuza-Luces, Gema Torres-Luque, Thomas Yvert, Catalina Santiago, Félix Gómez-Gallego, Jonatan R. Ruiz, and Alejandro Lucia. "Single and combined influence of ACE and ACTN3 genotypes on muscle phenotypes in octogenarians." European Journal of Applied Physiology 112, no. 7 (November 2, 2011): 2409–20. http://dx.doi.org/10.1007/s00421-011-2217-4.
Full textMurry, Benrithung, Neikethono Vakha, Nongthombam Achoubi, M. P. Sachdeva, and K. N. Saraswathy. "APOE, MTHFR, LDLR and ACE Polymorphisms Among Angami and Lotha Naga Populations of Nagaland, India." Journal of Community Health 36, no. 6 (April 3, 2011): 975–85. http://dx.doi.org/10.1007/s10900-011-9397-z.
Full textMisra, Usha K., Jayantee Kalita, Bindu I. Somarajan, Bishwanath Kumar, Moromi Das, and Balraj Mittal. "Do ACE (rs4646994) and αADDUCIN (rs4961) gene polymorphisms predict the recurrence of hypertensive intracerebral hemorrhage?" Neurological Sciences 33, no. 5 (December 24, 2011): 1071–77. http://dx.doi.org/10.1007/s10072-011-0903-y.
Full textKwok, T., J. Leung, Y. F. Zhang, D. Bauer, K. E. Ensrud, E. Barrett-Connor, and P. C. Leung. "Does the use of ACE inhibitors or angiotensin receptor blockers affect bone loss in older men?" Osteoporosis International 23, no. 8 (November 12, 2011): 2159–67. http://dx.doi.org/10.1007/s00198-011-1831-7.
Full textKim, Wook, Hyun Ik Cho, Ki Cheol Kim, Young Ho So, and Jang Gun Oh. "Relationships between digit ratio (2D:4D), ACE gene polymorphism, and physical performance in the Korean population." Genes & Genomics 33, no. 4 (August 2011): 407–12. http://dx.doi.org/10.1007/s13258-011-0039-8.
Full textKo, Seok-Chun, Min Cheol Kang, Jung-Kwon Lee, Hee-Guk Byun, Se-Kwon Kim, Seung-Cheol Lee, Byong-Tae Jeon, Pyo-Jam Park, Won-Kyo Jung, and You-Jin Jeon. "Effect of angiotensin I-converting enzyme (ACE) inhibitory peptide purified from enzymatic hydrolysates of Styela plicata." European Food Research and Technology 233, no. 6 (October 4, 2011): 915–22. http://dx.doi.org/10.1007/s00217-011-1585-7.
Full textValika, Ali A., and Mihai Gheorghiade. "Ace inhibitor therapy for heart failure in patients with impaired renal function: a review of the literature." Heart Failure Reviews 18, no. 2 (January 3, 2012): 135–40. http://dx.doi.org/10.1007/s10741-011-9295-6.
Full textKerkaert, Barbara, Frédéric Mestdagh, Tatiana Cucu, Kshitij Shrestha, John Van Camp, and Bruno De Meulenaer. "The impact of photo-induced molecular changes of dairy proteins on their ACE-inhibitory peptides and activity." Amino Acids 43, no. 2 (November 25, 2011): 951–62. http://dx.doi.org/10.1007/s00726-011-1157-y.
Full textCacciatore, Francesco, Giuseppe Bruzzese, Dino Franco Vitale, Antonio Liguori, Filomena de Nigris, Carmela Fiorito, Teresa Infante, et al. "Effects of ACE inhibition on circulating endothelial progenitor cells, vascular damage, and oxidative stress in hypertensive patients." European Journal of Clinical Pharmacology 67, no. 9 (March 29, 2011): 877–83. http://dx.doi.org/10.1007/s00228-011-1029-0.
Full textSun, Yuanxia, Shigeru Hayakawa, Masahiro Ogawa, Supaporn Naknukool, Yupin Guan, and Yoshiyuki Matsumoto. "Evaluation of angiotensin I-converting enzyme (ACE) inhibitory activities of hydrolysates generated from byproducts of freshwater clam." Food Science and Biotechnology 20, no. 2 (April 2011): 303–10. http://dx.doi.org/10.1007/s10068-011-0043-4.
Full textLee, Seung-Ju, Dong Sup Lee, Hyun-Sop Choe, Dong Choon Park, and Yong-Hyun Cho. "Evaluation of Seeplex® STD6 ACE Detection kit for the diagnosis of six bacterial sexually transmitted infections." Journal of Infection and Chemotherapy 18, no. 4 (2012): 494–500. http://dx.doi.org/10.1007/s10156-011-0362-7.
Full textMasud, Rizwan, and Irfan Zia Qureshi. "Tetra primer ARMS-PCR relates folate/homocysteine pathway genes and ACE gene polymorphism with coronary artery disease." Molecular and Cellular Biochemistry 355, no. 1-2 (May 13, 2011): 289–97. http://dx.doi.org/10.1007/s11010-011-0866-6.
Full textWang, Hui, Yongyu Li, Yongqiang Cheng, Lijun Yin, and Lite Li. "Effect of the Maillard Reaction on Angiotensin I-Converting Enzyme (ACE)-Inhibitory Activity of Douchi During Fermentation." Food and Bioprocess Technology 6, no. 1 (May 27, 2011): 297–301. http://dx.doi.org/10.1007/s11947-011-0596-5.
Full textGandhi, Gunjan Y., and William L. Isley. "Review: ACE inhibitors and angiotensin-receptor blockers reduce diabetes in hypertension and other CV risk factors." ACP Journal Club 146, no. 1 (January 1, 2007): 11. http://dx.doi.org/10.7326/acpjc-2007-146-1-011.
Full text